BMS 100 852 (Sprycel 100 mg)
Generic Name: dasatinib
Pill with imprint BMS 100 852 is White, Elliptical/Oval and has been identified as Sprycel 100 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of chronic myelogenous leukemia; acute lymphoblastic leukemia; leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 100 852
Sprycel
- Generic Name
- dasatinib
- Imprint
- BMS 100 852
- Strength
- 100 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-0852
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (18)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: BCR-ABL tyrosine kinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.